With the market steadily pushing above and beyond its all-time highs, it’s becoming increasingly difficult to find stocks with compelling valuations. With this in mind, we asked three of our contributors which stocks they think are still bargains that might be worth buying right now.
Category: Healthcare Law
PENCE: ‘The Obamacare nightmare is about to end!’
Vice President Mike Pence delivered a strong endorsement Saturday morning of the GOP’s replacement bill for the Affordable Care Act, which was introduced earlier in the week by House Republican leadership and supported by President Donald Trump. Pence, who spoke to constitutents in Kentucky, highlighted some of the pitfalls of Obamacare, including rising premiums and a lack of carrier options.
Trump has made his FDA pick – here’s what that could mean…
Gottlieb is a resident fellow at the American Enterprise Institute and venture partner at New Enterprise Associates. He previously served as former deputy commissioner of the FDA during George W. Bush’s presidency.
Trump Is Said to Pick Scott Gottlieb as Food and Drug Chief
Scott Gottlieb, a former deputy commissioner of the U.S. Food and Drug Administration, is President Donald Trump’s choice to lead the agency, according to people familiar with the matter. Gottlieb, 44, served in several senior positions at the FDA during the George W. Bush administration.
Biotech Stock Mailbag: Puma’s Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps
This week’s Biotech Stock Mailbag will address some current controversies and burning questions in our little corner of the investment world. Why the hell is Puma Biotechnology trading higher after the successful readout of Roche’s “APHINITY’ study of Perjeta in adjuvant breast cancer? What are the arguments for and against TG Therapeutics securing approval for ublituximab in high-risk chronic lymphocytic leukemia ? Did Aurinia Pharmaceuticals make a change to the primary endpoint of its phase III study of voclosporin in lupus nephritis? Are regulators okay with it? The March 2 announcement by Roche that Perjeta met the primary endpoint in the APHINITY study caused Puma shares to fall from $38 to an intraday low of $29.
Pharma, Bank Stocks Pull Wall St Lower
U.S. stock prices closed lower on Tuesday as weakness in drug and financial shares sent the S&P 500 and the Dow Jones Industrial Average to their first consecutive sessions of declines in more than a month. Pharmaceutical stocks came under pressure after U.S. President Donald Trump tweeted he was working on a “new system” to reduce drug prices in the industry, without providing details.
Wall St Pares Losses as Techs Offset Pharma Decline
President Donald Trump gestures as he arrives on Capitol Hill in Washington, Tuesday, Feb. 28, 2017, for his address to a joint session of Congress. U.S. stocks pared losses late Tuesday morning as a decline in drug stocks, triggered by President Donald Trump’s tweet about lowering drug prices, was countered by gains in technology shares.
Trump Sends Pharma Stocks Down With New Tweet on Drug Prices
President Donald Trump jumped back into the debate over drug pricing on Tuesday, sending pharmaceutical stocks down again with a tweet promising to lower medicine costs for American people. In a tweet shortly before 9 a.m. New York time, Trump said he’s working on a “new system where there will be competition in the drug industry.”
Market Recon: We Witness the Opening Kickoff of the Political Football on Health Care
“Character isn’t something you were born with and can’t change, like your fingerprints. It’s something you weren’t born with and must take responsibility for forming.”
House GOP Finally Puts Out Repeal Plan
House Speaker Paul Ryan, R-Wis., plans to send the bill to the House floor for a vote and then forward it to the Senate by the beginning of April. Employers would no longer face a tax for offering high-value “Cadillac” health plans under the latest House Republican plan to repeal and replace Obamacare.
Republicans Unveil Bill to Repeal and Replace Obamacare
Republicans unveiled their long-awaited legislation to repeal and replace the Affordable Care Act, taking them a step closer to fulfilling a vow they’ve been repeating since the health law’s passage in 2010. Called the American Health Care Act, House Republicans’ proposal released Monday would unwind much of Obamacare over the next three years.
The Marijuana Industry Has Some Brand-New Opposition
The marijuana industry has been practically unstoppable this decade. Just this past year alone, five states legalized medical cannabis , while the number of recreational weed states doubled to eight.
Stock plunges, trading halted in owner of Kay and Jared jewelry chains after Post report
The parent company of Sterling Jewelers, which owns Jared the Galleria of Jewelry and Kay Jewelers, halted trading in its stock Tuesday after shares plunged to a four-year low. The Washington Post reported on Monday evening that about 250 former employees allege in sworn statements that the company’s chief executive and other leaders fostered a culture of rampant sexual harassment and discrimination.
Trump Tells Health Insurers to Expect `Something Special’
President Donald Trump told major U.S. health insurers at a White House meeting Monday to expect “something special” to replace Obamacare, as the administration gets more involved in Republican efforts to repeal the health-care law. “We’re going to be talking about it tomorrow night during the speech,” Trump said, referring to his address to a joint session of Congress scheduled for Tuesday.
‘It saved my life’: Talk of Obamacare repeal worries addicts
In a Wednesday, Feb. 1, 2017 photo, Tyler Witten peers through a window at the Sanibel House, a residential addiction center in Catlettsburg, Ky. Witten, a former opioid addict, has gone through an addiction program and now works as a weekend staffer at the house.
Obamacare launched a new wave of start-ups. Now they’re bracing for what’s next.
Four years ago, Noah Lang saw an opportunity in Obamacare. With an eye toward the millions of people set to purchase health insurance on their own for the first time, the 29-year-old Silicon Valley entrepreneur founded a start-up, Stride Health, that helps them compare and choose between plans – and do it all from a smartphone.
Aetna, Humana Abandon $37 Billion Merger Blocked by Judge
Aetna Inc. ended its $37 billion takeover of Humana Inc., after deciding not to appeal a ruling by a federal judge who blocked the health insurers’ combination on antitrust grounds. The companies came to a mutual agreement to terminate the deal, and Aetna will pay Humana a $1 billion breakup fee, or about $630 million after taxes.
Rational on regulation
The first weeks of the Trump administration have not exactly been characterized by an excess of regular order. So there’s special reason to applaud a document it released that helps to make sense of one of the president’s controversial actions – an unprecedented executive order limiting regulation.
A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer’s Disease
Alzheimer’s disease is a terrible illness which affects an estimated 5.4 million Americans today. Alzheimer’s is also the 6th leading cause of death nationally.
Why Acorda Therapeutics Stock Is Jumping Today
The drugmaker’s stock is moving higher this morning in response to the news that its inhaledParkinson’s disease drug, CVT-301, hit the mark in a late-stage trial. According to the press release, patients receiving CVT-301 exhibited astatistically significant improvement in motor function whenexperiencing off periods compared to those taking a placebo.
Humana surprises in 4Q; will talk next steps with Aetna
Humana topped most expectations for the fourth quarter and said that next week it will detail both its outlook for the year and the next step in its proposed acquisition by Aetna. A federal judge rejected Aetna’s bid last month due in part to the potential impact on competition.
Cigna’s Profit Beats Estimates
Cigna, which is awaiting a ruling on the U.S. government’s lawsuit to block its acquisition by Anthem, reported a better-than-expected quarterly profit, helped by strength in its commercial business. Cigna’s results come a day after Anthem said it expected to break even or make a small profit in the Obamacare individual market in 2017 even as it considers pulling out of that business next year.
Side effect kills cancer patient in Stemline drug trial — Feuerstein
Stemline’s SL-401 has demonstrated robust overall tumor response rates in its clinical trial but the drug is also now tied to three patient deaths from capillary leak syndrome. Investors who bought into a $45 million Stemline Therapeutics stock offering on Jan. 19 were not told that one day prior to the financing, a cancer patient in a clinical trial died from a severe side effect, a type of low blood pressure, tied to the company’s drug SL-401.
Tuesday night deadline for ‘Obamacare’ coverage
Overnight Tuesday is the deadline to sign up for coverage under the federal health care law. Even if the ultimate fate of “Obamacare” is uncertain, there’s been no change for this year.
Better Buy: Inovio Pharmaceuticals vs. Incyte Corp.
Over the same period, shares of Incyte Corp. have risen a healthy 49.6% on the back of several intriguing developments. Both companies have catalysts to look forward to.
What Is the FICA Tax, and Why Do I Have to Pay It?
If you’ve ever received a paycheck from your employer, you’ve probably felt a sense of accomplishment and disappointment all at once. The accomplishment comes in the form of the cash that’ll be flowing into your bank account, whereas the disappointment comes from the realization that you may owe quite a bit of tax on the wages you’ve earned.
Vice President Pence promised to stop taxpayer-funded abortion…
Addressing the 44th annual March for Life on Friday, Vice President Mike Pence declared that it was a new day for anti-abortion activists in America. “This administration will work with Congress to end taxpayer funding for abortion and abortion providers, and we will devote those resources to health care services for women across America,” Pence told the crowd of thousands gathered on the National Mall.
Trump administration pulls back on HealthCare.gov ads
The Trump administration said Thursday night it is pulling back advertising to promote HealthCare.gov as open enrollment draws to a close for this year. The Health and Human Services Department said in a statement that the government has pulled back about $5 million in ads as part of an effort to cut costs.
Trump Administration Pulls Some Obamacare Ads as Deadline Nears
The Trump administration has pulled some advertising designed to encourage people to sign up for health insurance under the Affordable Care Act, days before the final deadline to buy 2017 health plans under the law. The Department of Health and Human Services withdrew about $5 million of advertising, according to Matt Lloyd, a spokesman for the department.
Federal judge swats Aetna-Humana insurer combo
A federal judge has rejected health insurer Aetna’s plan to buy rival Humana Inc. for about $34 billion and become a major player in the market for Medicare Advantage coverage. U.S. District Judge John Bates says in an opinion filed Monday that he largely agrees with federal regulators who contended that such a combination would hurt competition.
Aetna And Humana Stock Each Drop 2% In Heavy Volume After Federal Judge Blocks Merger
Aetna Inc. shares dropped 2.4% and Humana Inc. shares dropped 2.0% in heavy volume during midday trade Monday after The Wall Street Journal and Reuters reported that a federal judge had blocked their merger on antitrust grounds. The federal judge’s Monday decision said the DOJ had successfully argued that the deal could hurt consumers with Medicare Advantage plans, according to the WSJ.
3 Biotechs Likely to Be Acquired in 2017
The year is still young, but we’ve already seen acquisitions of Ariad and CoLucid . Which biotechs could be scooped up next in 2017? Here’s why Clovis Oncology The number of big companies battling to acquire Medivationin 2016 shows that the oncology space is hot.
What Does 2017 Hold for Medicare?
Medicare faces substantial uncertainty in 2017, as the incoming Trump administration has already promised to make major healthcare reforms. Although the president said during his campaign that he would not make cuts to Medicare, members of his cabinet and lawmakers in Congress might well see things differently.
Obamacare Failed Because It Made More Sense to Remain Uninsured
Now-former President Barack Obama’s legacy is defined by the passage of the Affordable Care Act, which is more commonly referred to as Obamacare. Obamacare completely changed the way consumers shopped for health insurance and received medical care.
Trump’s First Big Move: Repealing Obamacare Mandate
President Donald Trump late Friday took one of his first major policy actions by issuing an executive order undoing one of the key pillars of the Affordable Care Act, the individual mandate requiring all Americans to carry health insurance or pay a penalty. The newly sworn-in Trump in the Oval Office signed an order giving federal agencies authority to undo rules created under the ACA that obligate them to enforce the penalty for people who do not purchase health insurance as required by the law, also known as Obamacare.
Trump Order Declares He’ll Seek – Prompt Repeal’ of Obamacare
President Donald Trump signed an executive order Friday commanding federal agencies to try to waive or delay requirements of Obamacare that impose economic or regulatory burdens on states, families, the health-care industry and others. The order declares that Trump’s administration will seek the “prompt repeal” of the law and that the government should prepare to “afford the states more flexibility and control to create a more free and open healthcare market.”
Trump Declares in Order He’ll Seek – Prompt Repeal’ of Obamacare
President Donald Trump signed an executive order Friday commanding federal agencies to try to waive or delay requirements of Obamacare that impose economic or regulatory burdens on states, families, the health-care industry and others. The order declares that Trump’s administration will seek the “prompt repeal” of the law, and that the government should prepare to “afford the states more flexibility and control to create a more free and open healthcare market.”
7 Obamacare Provisions That Could Be Eliminated As Soon As Jan. 20
By the end of this week, President-elect Donald Trump will officially become the 45th president of the United States. With his ascent into the Oval Office will also come a changing of the guard when it comes to policy.
Trumpcare, Not Obamacare, Could Be a Job Killer
In less than one week’s time Donald Trump is set to become the 45th president of the United States, which seemed mighty unlikely about a year and a half ago when campaigning began. While his agenda once in office is seemingly a mile long, at the top of the list appears to be the repeal of the Affordable Care Act, which you probably know best as Obamacare.
What Does 2017 Hold for Obamacare?
The Affordable Care Act became law in 2010, and the law has remained controversial long after its enactment. Until recently, policymakers didn’t expect any major changes to Obamacare during 2017, but they acknowledged that the outcome of the 2016 presidential election would have huge implications for the fate of healthcare reform going forward.